Diabetes affects 537 million people globally, and cases are increasing in many regions. However, the diabetes medicines available as standard in high-income countries are often inaccessible in most low-income countries, mainly due to high prices. Dr Helen Bygrave, MSF Access Campaign Advisor for Non-communicable Diseases explained this phenomenon